Concepedia

Kazushi Numata

KN

Statistics

Publications

140

Citations

10.9K

H-Index

50

Active since

1990

Affiliations

Yokohama City University(Current)

Yokohama City University Medical Center

Kindai University

Kanagawa Prefectural Hospital Organization

Kanagawa Cancer Center

Kazushi Numata is an author at Yokohama City University specializing in medicine, oncology, and hepatocellular carcinoma.

Publications per year

1990–2024

140

Publications

140

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

Andrew X. Zhu, Richard S. Finn, Julien Edeline et al. · The Lancet Oncology · 2018 · 2.5K citations

Medicine, Oncology, Pharmacology +11

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study

Michael S. Lee, Baek‐Yeol Ryoo, Chih‐Hung Hsu et al. · The Lancet Oncology · 2020 · 567 citations

Medicine, Oncology, Pharmacology +14

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

Josep M. Llovet, Masatoshi Kudo, Philippe Merle et al. · The Lancet Oncology · 2023 · 421 citations · Full text

Medicine, Oncology, Pharmacology +12

Midterm outcomes in patients with intermediate‐sized hepatocellular carcinoma

Manabu Morimoto, Kazushi Numata, Masaaki Kondou et al. · Cancer · 2010 · 329 citations

Medicine, Oncology, Surgery +13

1–5 of 140